Modern Inc. said Tuesday that it has initiated a request for full approval in the United States of its COVID-19 vaccine, which is currently only authorized for emergency use in the country.

The news comes weeks after his rival Pfizer Inc. and its German partner BioNTech SE. request full approval of your vaccine COVID-19 in United States.

Full approval of vaccines, which are at the forefront of global immunization efforts, could be an important step in dispelling doubts about vaccines, a growing concern in the United States and other nations.

SIGHT: COVID-19 | Moderna says her vaccine is safe and effective in teens

Moderna said it will continue to submit data to the Food and Drug Administration (FDA) from the United States on an ongoing basis for the next several weeks with a priority review request.

Once this data input is completed, the FDA It will notify the company when its review is formally accepted, Moderna added.

As part of a continuous or real-time submission, a laboratory may submit entire sections of its marketing application for review by the laboratory. FDA, rather than waiting until all sections of the application are completed before the application can be comprehensively reviewed.

SIGHT: COVID-19 | Pfizer and Moderna vaccines appear effective against Indian variant of coronavirus



Disclaimer: If you need to update/edit/remove this news or article then please contact our support team Learn more


The News 24 is the place where you get news about the World. we cover almost every topic so that you don’t need to find other sites.